In MCF-7 and MDA-MB-231 breast cancer cells, artesunate was capable of inhibiting the proliferation of these cancer cells through inducing autophagy, which was indicated by up-regulation of Beclin-1 and aggregation of LC3-II and increasing sensitivity to the chemotherapy drug epirubicin (84). The gene discussed is BECN1; the disease is breast carcinoma.